FDA Inspection 892079 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on August 20, 2014 in Port Jefferson Station, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 20, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Port Jefferson Station, NY (United States)